The United States Food and Drug Administration will organise meetings with an independent group of experts to review data of coronavirus vaccine candidates and advise the agency, FDA commissioner Stephen Hahn has said.

"The meetings will reinforce the transparency of the process as FDA reviews data from trials now underway," Hahn said in a post on Twitter.